RacGAP1 Is a Novel Downstream Effector of E2f7-Dependent Resistance to Doxorubicin and Is Prognostic for Overall Survival in Squamous Cell Carcinoma

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-15-0076
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

C-Reactive Protein to Prealbumin Ratio (CPR): A Novel Inflammatory-Nutritional Prognostic Factor for Predicting Cancer-Specific Survival (CSS) and Overall Survival (OS) in Patients With Resectable Esophageal Squamous Cell Carcinoma

Journal of Oncology
Oncology
2019English

A Six-mRNA Prognostic Model to Predict Survival in Head and Neck Squamous Cell Carcinoma

Cancer Management and Research
Oncology
2018English

Phenotype of Tumor Lymphatic Vessels Is a Prognostic Factor in Human Tongue Squamous Cell Carcinoma

Oncology Letters
Cancer ResearchOncology
2010English

What Is the Prognostic Significance of Ki-67 Positivity in Oral Squamous Cell Carcinoma?

Journal of Cancer
Oncology
2016English

Resistance to Dasatinib Is Associated With the Activation of Akt in Oral Squamous Cell Carcinoma

Translational Research in Oral Oncology
2017English

RETRACTED ARTICLE: Psoriasin (S100A7) Is a Novel Biomarker for Lung Squamous Cell Carcinoma in Humans

Cancer Cell International
Cancer ResearchOncologyGenetics
2015English

High YKL-40 Is Associated With Poor Survival in Patients With Renal Cell Carcinoma: A Novel Independent Prognostic Marker

Scandinavian Journal of Urology
UrologyNephrology
2017English

Expression of KLF5 Is a Prognostic Factor for Disease-Free Survival and Overall Survival in Patients With Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2006English

A Novel Long Non-Coding RNA, AC012456.4, as a Valuable and Independent Prognostic Biomarker of Survival in Oral Squamous Cell Carcinoma

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy